endometrial carcinoma
子宫内膜癌
2025-10-08 15:05 浏览次数 24
子宫内膜癌
The outbreak rate of the endometrial carcinoma increased gradually in the recent years.
近年子宫内膜癌的发病率有逐渐增高的趋势。
METHODS Effects of these substances on liver cancer and endometrial carcinoma cell lines were determined by MTT.
方法用MTT测定其抗肝癌细胞和子宫内膜癌的活性。
Methods: Retrospectively laralyze the clinic and pathological features of 39 cases with advanced endometrial carcinoma from 1995 to 2005.
方法:回顾性分析我院1995.1~2005.1月间收治的39例晚期子宫内膜癌患者临床病理资料和随访结果。
Objective to investigate the role of estrogen receptor-related receptor (ERR), a subfamily of orphan receptors, in the tumorigenesis of endometrial carcinoma and to evaluate the clinical significance.
目的探讨雌激素受体相关受体(err)亚型在子宫内膜癌组织中的表达及其临床意义。
This paper review the expression of cytokine expression in endometrial carcinoma and its role in the tumor microenvironment.
本文就这些过表达的细胞因子在子宫内膜癌中的表达情况及其在肿瘤微环境中的作用进行综述。
The rates of CXCR4 and SDF-1 protein expressions were 100% in glandular cells of human normal endometrial tissues, while 90.9% and 93.2% in glandular cells of endometrial carcinoma tissues.
CXCR4和SDF - 1在正常和良性病变的子宫内膜组织腺体细胞中的阳性表达率为100%,在子宫内膜癌组织的腺体细胞中的阳性表达率分别为90.9%和93.2%。
Objective to study the expression of matrix metalloproteinase-12 (MMP-12) in human endometrial carcinoma tissue and its relation to the invasion and metastasis of endometrial carcinoma.
目的通过研究基质金属蛋白质酶12 (MMP - 12)在子宫内膜癌中的表达,探讨其与子宫内膜癌浸润转移的关系。
Conclusion Combined treatment raises the survival of the recurrent endometrial carcinoma patients, in which chemotherapy plays a leading role and influences the prognosis remarkably.
结论综合治疗可以提高复发子宫内膜癌患者的生存率,化疗在其中起主导性作用,对患者预后有重要影响。
The expression level of TM is correlated with the metastasis of endometrial carcinoma and can be used as a new index for judging the progression and prognosis of endometrial carcinoma.
TM表达水平与子宫内膜癌的转移有关,有望成为判断子宫内膜癌患者病情发展和预后的一项新指标。
The expression of HLA-DR in most cases with normal endometrium was negative. The HLA-DR expression in endometrial carcinoma was significantly higher than that in normal endometrium.
正常子宫内膜HLA鄄DR多数呈阴性表达,而子宫内膜癌中HLA鄄DR表达高于正常子宫内膜。
Methods: er and PR of32cases of endometrial carcinoma were measured by immunohistochemical method.
方法:用免疫组化法对32例子宫内膜癌标本进行ER、PR的检测。
Methods: in a retrospective study, the estrogen level and the clinical and pathological data from 92 patients with endometrial carcinoma were analyzed.
方法:对92例绝经后子宫内膜癌的雌激素水平及其临床病理资料进行回顾性分析。
To investigate the expression of HLA-DR in endometrial carcinoma and its clinical significance.
探讨HLA鄄DR在子宫内膜癌中的表达及其临床意义。
Objective: to study the effect of Uroacitide (CDA-2) on the proliferation, differentiation and autocrine of human endometrial carcinoma cell line EAC.
目的:研究尿多酸肽(CDA - 2)对EAC人子宫内膜癌细胞增殖、分化及细胞自分泌的影响。
Conclusion High dose mifepristone can promote apoptosis of endometrial carcinoma but has no effect on telomerase activity.
结论口服大剂量米非司酮可促进子宫内膜癌细胞凋亡,但对端粒酶活性无明显影响。
Purpose:To investigate the expression of P16 and cyclinD1 in endometrial carcinoma and their clinical significance.
目的:研究P16和细胞周期蛋白D1在子宫内膜癌中的表达及其临床意义。
Conclusion High expression of these genes in estrogen-dependent endometrial carcinoma may provide insights into their roles in the pathogenesis and prognosis of this malignancy.
结论某些基因在雌激素依赖型子宫内膜癌中高表达,为进一步研究此类基因在子宫内膜癌发病过程的作用及预后奠定了基础。
Experirnent methods include the DNA preparation of endometrial carcinoma tissues, RNA preparation, protein preparation, PCR expand, DHPLC analyse and DNA sequencing etc.
实验方法包括子宫内膜癌组织dna制备、RNA制备、蛋白质制备、P CR扩增、DHPLC分析、DNA直接测序等步骤。
Objective To screen the sensitive chemotherapeutic agents to human endometrial carcinoma cell line-1 (HECCL-1) and study its mechanism.
目的利用人子宫内膜癌细胞株(HECCL 1)筛选对人子宫内膜癌敏感的化学药物,并探讨其作用机制。
Objective to study the expression of matrix metalloproteinase 13 (MMP-13) protein in human endometrial carcinoma tissue and its relation to the invasion and metastasis of endometrial carcinoma.
目的研究基质金属蛋白酶13 (MMP -13)在子宫内膜癌组织中的表达状况与侵袭及转移间的关系。
Objective to analyze the treatment of endometrial carcinoma and the factors of prognosis.
目的探讨子宫内膜癌的治疗及预后相关因素。